Beyond Memory Loss: Optimizing The Role Of Primary Care In Assessing & Treating Agitation In Alzheimer’s Dementia

Challenges in the treatment of agitation associated with Alzheimer’s Dementia (AAD) presents across multiple treatment settings. As the prevalence of Alzheimer’s Dementia continues to significantly increase, Primary Care will play an important role in not only assessing for cognitive declines in older adults but also in managing the diagnosis and treatment of AAD. This webinar dives into the unmet needs within this patient population and features experts in the management of AAD within the primary care setting. Specifically, presenters review the prevalence of AAD, describe challenges in diagnosing AAD, and explore the potential pathobiological correlates in AAD. The webinar also discusses the clinical and humanistic burden of AAD, as well as highlights the current guidelines for nonpharmacological and pharmacological treatments of this complex and prominent complication of an already devastating disease.

C. Brendan Montano, MD, PC

Director and Principal Investigator for Connecticut Clinical Research in Cromwell, Connecticut

More

Dr. Montano is Director and Principal Investigator for Connecticut Clinical Research in Cromwell, Connecticut, where he also holds a private practice in internal medicine, specializing in preventative medicine and mood disorders. In addition, he is an attending physician at Middlesex Memorial Hospital in Middletown, Connecticut.

Elika Hefazi, PharmD, BCPP (OPDC)

Medical Science Liaison

Elizabeth DiNapoli, PhD (OPDC)

Senior Medical Science Liaison

More

Dr. DiNapoli earned her PhD from the University of Alabama.

Speaker Dr. C. Brendan Montano is a paid consultant for Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)
Moderators Elika Hefazi, PharmD, BCPP and Beth DiNapoli, PhD are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)